Clinical Trials Browser

Recurrence × denileukin diftitox × Clear all

NCT01432483 2015-01-26

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

No longer available

Neoplasms, Recurrence

NCT00801918 2013-05-15

Denileukine Diftitox for Relapsed ALCL

Phase 2 Withdrawn

Lymphoma, Recurrence, Lymphoma, Large-Cell, Anaplastic